Cellebrite DI (CLBT) Gross Profit (2020 - 2025)

Cellebrite DI's Gross Profit history runs 6 years deep, the most recent figure standing at $109.1 million for Q4 2025.

• On a quarterly basis, Gross Profit rose 19.37% year-over-year to $109.1 million in Q4 2025; TTM through Dec 2025 was $400.5 million, a 18.28% increase from a year earlier, with the FY2025 full-year figure at $400.5 million, up 18.28% from the prior year.
• Gross Profit rose to $109.1 million in Q4 2025 per CLBT's latest filing, from $105.7 million in the prior quarter.
• Across five years, Gross Profit topped out at $109.1 million in Q4 2025 and bottomed at $45.1 million in Q1 2021.
• The 5-year median for Gross Profit is $67.5 million (2023), against an average of $71.7 million.
• Across the five-year window, Gross Profit advanced 0.76% in 2022 and advanced 29.73% in 2024, its largest moves.
• Year by year, Gross Profit stood at $55.6 million in 2021, then climbed by 11.36% to $61.9 million in 2022, then climbed by 26.19% to $78.1 million in 2023, then rose by 17.07% to $91.4 million in 2024, then gained by 19.37% to $109.1 million in 2025.
• Per Business Quant, the three latest CLBT Gross Profit figures stand at $109.1 million (Q4 2025), $105.7 million (Q3 2025), and $95.6 million (Q2 2025).